MedTrace Logo

Lutein Influence on Macula of Persons Issued From Amd Parents

NCT01269697 · Status: COMPLETED · Phase: PHASE3 · Type: INTERVENTIONAL · Enrollment: 120

Last updated 2013-05-20

No results posted yet for this study

Summary

Age-related macular degeneration (AMD) is a degenerative disease of the centre of the retina (named macula) and is the leading cause of blindness in industrialized countries. There is growing interest in the potential preventive role of two carotenoids (lutein and zeaxanthin) of dietary origin, which specifically accumulate in the macula, where they form the macular pigment. A first step towards the demonstration of a preventive effect of macular pigment for AMD consists in the evaluation of the effect of lutein and zeaxanthin supplementation on their plasma and retinal concentrations.

Conditions

  • Persons Issued From Amd Parents

Interventions

DIETARY_SUPPLEMENT

Nutrof Total

2 capsules 2 times per day during 6 month

DIETARY_SUPPLEMENT

Placebo Nutrof total

2 capsules 2 times per day during 6 month

Sponsors & Collaborators

  • Laboratoires Thea

    collaborator INDUSTRY

  • University Hospital, Bordeaux

    lead OTHER

Principal Investigators

  • Jean-François KOROBELNIK, Professor · University Hospital Bordeaux, France

  • Geneviève CHENE, Professor · University Hospital Bordeaux, France

Study Design

Allocation
RANDOMIZED
Purpose
PREVENTION
Masking
DOUBLE
Model
PARALLEL

Eligibility

Min Age
40 Years
Max Age
70 Years
Sex
ALL
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2011-01-31
Primary Completion
2013-01-31
Completion
2013-01-31

Countries

  • France

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT01269697 on ClinicalTrials.gov